Alendronate Sodium
Closed Solicitation Posted
This opportunity was awarded. See its 2 award notices in the notice history.
- Solicitation number
- SPE2D221R0104
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
-
- Jason Wray jason.wray@dla.mil (445) 737-6304
- Courtney Hunter-Stangler courtney.hunter-stangler@dla.mil (215) 737-6845
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical, a defense agency specializing in medical supply chain procurement, is seeking to acquire Alendronate Sodium through Solicitation SPE2D221R0104. This pharmaceutical procurement falls under the NAICS category of Pharmaceutical Preparation Manufacturing and PSC category of Drugs and Biologicals. The solicitation was originally posted on February 19, 2021, with proposals due by March 22, 2021. While specific evaluation criteria are not explicitly detailed in the available documents, the procurement appears to be structured as a multi-year contract with multiple option periods. The solicitation suggests a comprehensive procurement process for this specific pharmaceutical product, potentially intended to support military medical supply needs.
The solicitation indicates no specific set-aside designations, meaning the opportunity is open to all qualified vendors. Exelan Pharmaceuticals Inc. appears to be the incumbent or current contractor, having been awarded contract SPE2D2-21-D-0134 and subsequently receiving multiple contract modifications extending the performance period. The contract has already been modified multiple times, with current extensions running through June 7, 2026, suggesting a potentially significant multi-year procurement strategy. While exact award values are not specified in the provided documents, the repeated modifications and extended timelines indicate a substantial and ongoing pharmaceutical supply arrangement. The place of performance is likely to be within the Defense Logistics Agency's medical supply chain infrastructure, supporting troop medical requirements across various military installations.
Notice text
4 versions
Update #4 · Latest ·
Option Year 4 invoked for the period of June 08, 2025 through June 07, 2026.
Solicitation SPE2D221R0104 Alendronate Sodium
Update #3 ·
Option Year 3 invoked for the period of June 08, 2024 through June 07, 2025.
Solicitation SPE2D221R0104 Alendronate Sodium
Update #2 ·
Option Year 1 invoked for the period of June 08, 2022 through June 07, 2023.
Solicitation SPE2D221R0104 Alendronate Sodium
Update #1 ·
Solicitation SPE2D221R0104 Alendronate Sodium
Attachments
| File | Type | Posted |
|---|---|---|
| SF30_SPE2D221D0134P00008 - Signed.PDF | ||
| eProcurement - SPE2D2-21-D-0134-P00005 - Signed.PDF | ||
| Signed SPE2D221D0134 P00004.pdf | ||
| SF30_SPE2D221D0134P00002 Signed.PDF.pdf | ||
| Option Year 1 Modification SPE2D2-21-D-0134 P00001.pdf | ||
| Alendronate Sodium Solicitation SPE2D2-21-R-0104.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Alendronate Sodium | Award Notice | |
| Manufacture/Distributor Br-Philadelp | Award Notice | |
| Alendronate Sodium | Solicitation | |
| Alendronate Sodium | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity